Axial Biotech Launches Scoliscore AIS Prognostic Test for Scoliosis

Axial Biotech has launched its Scoliscore AIS Prognostic Test for scoliosis, to be marketed by DePuy Spine, according to a release from Axial Biotech.

Advertisement

Scoliscore AIS is a saliva-based genetic test to predict the risk of progression of scoliosis, an abnormal lateral curvature of the spine.

Read Axial Biotech’s release about its Scoliscore AIS Prognostic Test.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.